CG Oncology CGON Cash Flow Statement
| FY'25 | FY'24 | ||
|---|---|---|---|
| -$161M-82.9% | -$88.04M-81.1% | ||
| $1.45M+4,416% | $32K+88.2% | ||
| $26.68M+134% | $11.4M+646% | ||
| -$132.35M-68.1% | -$78.71M-72.3% | ||
| $134K-43.0% | $235K— | ||
| —— | —— | ||
| $153.89M-75.5% | $628.28M+599% | ||
| —— | —— | ||
| -$132.48M-67.8% | -$78.95M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does CG Oncology's cash flow data come from?
- Every line is extracted from CG Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.